Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1986 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Guidance for the diagnosis and treatment of hypolipidemia disorders.
J Clin Lipidol. 2022 Nov-Dec;16(6):797-812. doi: 10.1016/j.jacl.2022.08.009. Epub 2022 Sep 29.
J Clin Lipidol. 2022.
PMID: 36243606
Free article.
Review.
We summarize the genetic basis of these disorders, provide guidance in their diagnosis and suggest treatment regimens including high dose fat-soluble vitamins as therapeutics. A section on preconception counseling and other special considerations pertaining to pregnancy is …
We summarize the genetic basis of these disorders, provide guidance in their diagnosis and suggest treatment regimens including high dose fa …
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, Ogura M, Ishibashi S, Okazaki S, Hirayama S, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M.
Takahashi M, et al.
J Atheroscler Thromb. 2021 Oct 1;28(10):1009-1019. doi: 10.5551/jat.RV17056. Epub 2021 May 16.
J Atheroscler Thromb. 2021.
PMID: 33994405
Free PMC article.
Review.
However, it cannot fully prevent or restore impaired function. Novel therapeutic modalities that improve quality of life and prognosis are awaited. ...Registry research on ABL is currently ongoing to better understand the disease burden and unmet needs of this life-threate …
However, it cannot fully prevent or restore impaired function. Novel therapeutic modalities that improve quality of life and prognosi …
Item in Clipboard
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
Brown EE, Sturm AC, Cuchel M, Braun LT, Duell PB, Underberg JA, Jacobson TA, Hegele RA.
Brown EE, et al.
J Clin Lipidol. 2020 Jul-Aug;14(4):398-413. doi: 10.1016/j.jacl.2020.04.011. Epub 2020 May 7.
J Clin Lipidol. 2020.
PMID: 32507592
Potential benefits of genetic testing include providing a firm diagnosis in many cases, guiding optimal management and prevention strategies, advancing care strategies beyond currently available treatments, and contributing to overall scientific progress. ...
Potential benefits of genetic testing include providing a firm diagnosis in many cases, guiding optimal management and prevention strategies …
Item in Clipboard
Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
Kwiterovich PO Jr, Stewart P, Probstfield JL, Stinnett S, Chambless LE, Chase GA, Jacobs DR, Morrison JA.
Kwiterovich PO Jr, et al.
Circulation. 1986 Jan;73(1 Pt 2):I30-9.
Circulation. 1986.
PMID: 3940681
A positive screening test for hyperlipidemia was defined as an elevated level of plasma total cholesterol or triglyceride at both visit 1 and visit 2. A positive screening test for hypolipidemia was defined as a reduced plasma total cholesterol level at both visits. ...
A positive screening test for hyperlipidemia was defined as an elevated level of plasma total cholesterol or triglyceride at both visit 1 an …
Item in Clipboard
Cite
Cite